FGFR3-related chondrodysplasia: genes and variants
Explore variant evidence for FGFR3-related chondrodysplasia across 1 analyzed protein (FGFR3). Linked ClinVar records include 20 pathogenic or likely pathogenic variants, 84 variants of uncertain significance and 23 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to FGFR3-related chondrodysplasia
FGFR3: Fibroblast growth factor receptor 3
It normally restrains growth-plate chondrocyte proliferation while regulating multiple developmental pathways. Activating germline variants cause achondroplasia and related skeletal dysplasias, while somatic activating alterations are common in bladder cancer and some other tumors.
20 ClinVar pathogenic / likely pathogenic and 107 uncertain variants in FGFR3 have source records linked to FGFR3-related chondrodysplasia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to FGFR3-related chondrodysplasia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FGFR3 R248C | 248 | Extracellular | Pathogenic / likely pathogenic (★★★★) |
| FGFR3 N540D | 540 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR3 N540T | 540 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR3 N540S | 540 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR3 N540K | 540 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR3 K650Q | 650 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR3 K650N | 650 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR3 R621H | 621 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR3 S249C | 249 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FGFR3 Y278C | 278 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR3 S279C | 279 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR3 S344C | 344 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR3 Y373C | 373 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FGFR3 G375C | 375 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FGFR3 G380R | 380 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| FGFR3 S348C | 348 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR3 S371C | 371 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FGFR3 N428S | 428 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| FGFR3 T546K | 546 | Protein kinase | Pathogenic / likely pathogenic (★) |
| FGFR3 P550H | 550 | Protein kinase | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in FGFR3-related chondrodysplasia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| FGFR3 S249Y | 249 | Extracellular | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; S249C at the same position is pathogenic; seen in 4.8e-06 of gnomAD DNA copies; REVEL 0.853 |
| FGFR3 R621C | 621 | Protein kinase | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (1A); R621H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| FGFR3 S249F | 249 | Extracellular | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; S249C at the same position is pathogenic; REVEL 0.817 |
| FGFR3 R621L | 621 | Protein kinase | Uncertain (★★) | +6: in a 3D region that tolerates change poorly (1A); R621H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| FGFR3 K650R | 650 | Protein kinase | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; K650Q at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.62 |
| FGFR3 K650E | 650 | Protein kinase | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; K650Q at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
Which prediction tools work for FGFR3-related chondrodysplasia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 93 out of 100
- AlphaMissense: 92 out of 100
- MetaSVM: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 90 out of 100
- SIFT: 88 out of 100
- SpliceAI: 70 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 67 out of 100
- Pangolin: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Hypochondroplasia also has ClinVar records linked to FGFR3 variants; they fall partly in the same places as the FGFR3-related chondrodysplasia variants (15 pathogenic / likely pathogenic).
- Achondroplasia also has ClinVar records linked to FGFR3 variants; they fall in the same places as the FGFR3-related chondrodysplasia variants (9 pathogenic / likely pathogenic).
- Thanatophoric dysplasia also has ClinVar records linked to FGFR3 variants; they fall partly in the same places as the FGFR3-related chondrodysplasia variants (8 pathogenic / likely pathogenic).
- Urinary bladder cancer also has ClinVar records linked to FGFR3 variants; they fall mostly in different places as the FGFR3-related chondrodysplasia variants (3 pathogenic / likely pathogenic).
Diseases related to FGFR3-related chondrodysplasia
- Connective tissue disease, also linked to FGFR3
- Colorectal cancer, also linked to FGFR3
- Urinary bladder cancer, also linked to FGFR3
- Hypochondroplasia, also linked to FGFR3
- Colon carcinoma, also linked to FGFR3
- Achondroplasia, also linked to FGFR3
- Thanatophoric dysplasia, also linked to FGFR3
- Common craniosynostosis syndromes, also linked to FGFR3
- LADD syndrome, also linked to FGFR3
- Severe achondroplasia - developmental delay - acanthosis nigricans, also linked to FGFR3
- Epidermal nevus, also linked to FGFR3
- Renal cell carcinoma, also linked to FGFR3
Frequently asked questions
Which genes have records linked to FGFR3-related chondrodysplasia?
This view contains 1 analyzed proteins: FGFR3. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 20 pathogenic or likely pathogenic variants, 84 variants of uncertain significance and 23 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 6 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 135 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center